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A Novel Role for the Major Histocompatibility
Complex Class II Transactivator CIITA
in the Repression of IL-4 Production
genes (Chin et al., 1994; Chang and Flavell, 1995). In
addition, introduction of the CIITA gene driven by a con-
stitutive promoter is sufficient to activate MHC class II
genes in plasmacytoma cells or mouse T cells, where
MHC class II genes are not normally expressed (Silacci
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University of Michigan Medical School et al., 1994; Chang et al., 1995). These data suggest
that CIITA is a limiting potent transcriptional activatorAnn Arbor, Michigan 48109
³Howard Hughes Medical Institute regulating APC function. The significance of CIITA func-
tion in vivo was further confirmed by the generation ofSection of Immunobiology
Yale School of Medicine CIITA2/2 mice (Chang et al., 1996). The CIITA2/2 mice
do not express conventional MHC class II molecules onNew Haven, Connecticut 06510
the surface of professional APC. As a consequence,
very few mature CD4 T cells are present in peripheral
lymphoid organs and CIITA2/2 mice are impaired in theSummary
T-dependent antigen response (Chang et al., 1996).
Thus, CIITA2/2 mice display a phenotype similar to pa-Class II transactivator (CIITA) is known as a coactiva-
tients with severe combined immunodeficiency disease,tor for MHC class II gene expression in antigen-pres-
the bare lymphocyte syndrome (BLS). BLS group A pa-enting cells. Surprisingly, when CIITA2/2 CD4 T cells
tients lack MHC class II expression on APC, which iswere stimulated in the presence of IL-12, they pro-
due to a mutation in the CIITA gene (Steimle et al., 1993).duced not only IFNg but also high levels of IL-4. The
The expression of the CIITA gene is inducible by IFNgIL-4 production is due to the accumulation of IL-4 gene
through signaling from JAK1 kinase to the Stat1 tran-transcripts in Th1 cells. This transcriptional control is
scription factor (Muhlethaler-Mottet et al., 1998). Al-observed in T cells differentiating to the Th1 but not
though CIITA is a potent transcriptional activator, it isTh2 lineage, consistent with induction of expression
not known to bind directly to DNA and the mode ofof the CIITA gene in T cells by IFNg. Thus, in addition to
CIITA action is not yet understood. It has been shownits role in transactivation of genes involved in antigen
that acidic, proline/serine/threonine-rich and GTP-bind-presentation, CIITA plays a critical role during the T
ing regions of CIITA are critical for its function in MHCcell differentiation by negatively regulating the IL-4
class II gene transactivation (Chin et al., 1997a). Al-gene transcription.
though the role of the carboxyl terminus of CIITA is not
well characterized, the carboxy-terminal 41 amino acidsIntroduction
of CIITA are indispensable for the activation of MHC
class II gene expression (Chin et al., 1997b). CIITA mayMajor histocompatibility complex (MHC) class II molecules
function as a transcriptional coactivator interacting withare heterodimeric cell surface glycoproteins whose ex-
the transcription factors bound to the MHC class II pro-pression is critical for the development of CD4 T cells
moter (Hong and Glimcher, 1995). Recently, it has beenand to the ability of vertebrates to mount an immune
shown that CIITA is required for the assembly of tran-response. These molecules are expressed on antigen-
scription factor complexes on the promoters of genespresenting cells such as B cells, macrophages, and den-
that are activated by CIITA such as MHC class II promot-dritic cells, which take up, process, and present antigens
ers in IFNg inducible cells, but not in B cells (Wright etto CD4 T cells. The expression of MHC class II on B
al., 1998).cells is required for the collaboration between B and T
Interleukin 4 (IL-4) is a major cytokine produced by Tcells, which in turn is necessary for an efficient antibody
helper type 2 (Th2) cells that are involved in the regula-response. These molecules are also expressed on epi-
tion of antibody production, hematopoiesis, inflamma-thelial cells of the thymus, where thymocytes go through
positive and negative selection to generate the mature tion, and development of effector T cell responses (Mos-
T cell repertoire. The proper expression of MHC class mann and Coffman, 1989; Tepper et al., 1990; Paul, 1991;
II molecules is therefore crucial to regulate immune Pfeiffer et al., 1991; Rooney et al., 1994; Carter and
responses. Specifically, the lack of MHC class II ex- Dutton, 1996; Brown and Hural, 1997). Dysregulated ex-
pression can cause immunodeficiency, whereas aber- pression of IL-4 has been implicated in allergy, autocrine
rant expression might result in autoimmune responses growth of tumors, and susceptibility to some infectious
(reviewed in Mach et al., 1996). diseases. Although the molecular mechanism for the
The MHC class II transactivator (CIITA) was initially tissue-specific expression of the IL-4 gene has not been
identified as a critical transcription factor that is required well understood, production of IL-4 is controlled primar-
for both constitutive and IFNg inducible expression of ily by transient activation of transcription induced by
MHC class II genes (Steimle et al., 1993, 1994; Chang the binding of nuclear factors to 59 regulatory regions
et al., 1994). CIITA also activates other genes involved of the IL-4 promoter. Therefore, the cis elements and
in antigen presentation such as invariant chain and H2-M transcription factors of the IL-4 gene have been exten-
sively studied (reviewed in Brown and Hural, 1997).
IL-4 gene transcription is induced during Th2 cell dif-§ To whom correspondence should be addressed (e-mail: heechang@
umich.edu). ferentiation in response to antigen stimulation partly due
Immunity
378
to two transcription factors, c-maf and GATA-3, which
are reported to be selectively expressed in Th2 but not
Th1 cells (Ho et al., 1996; Zhang et al., 1997; Zheng and
Flavell, 1997). Both c-Maf and GATA-3 are able to induce
Th2 cytokine production in Th1 or B cells, suggesting a
specific role for these factors in regulating Th2 cytokine
production. In addition, NF-AT, NIP45, NF-IL-6, and
AP-1 participate in the activation of the IL-4 gene (Davy-
dov et al., 1995; Rooney et al., 1995; Hodge et al., 1996a;
Kaplan et al., 1996; Rincon and Flavell, 1997; Rincon et
al., 1997). One of the STAT family members, Stat6, is
rapidly activated by IL-4 receptor ligation and binds to
the IL-4 promoter and the silencer (Lederer et al., 1996;
Kubo et al., 1997). Although it is not clear whether Stat6
plays a direct role in IL-4 gene transcription, the critical
role of Stat6 in Th2 development was demonstrated by
the targeted disruption of the Stat6 gene in mice (Kaplan
et al., 1996; Shimoda et al., 1996; Takeda et al., 1996).
It has been shown that naive murine CD4 T cells ini-
tially transcribe both IFNg and IL-4 with stimulation
(Mosmann et al., 1986; Kamogawa et al., 1993). As differ- Figure 1. Flow Cytometric Analysis of Lymphocytes
entiation toward Th1 and Th2 effector cells proceeds, Lymphocytes of CIITA2/2xI-E mice express the I-E transgene (A).
The transgene expression is sufficient to mediate positive selectionsubstantial levels of IFNg and IL-4 mRNA accumulate,
of mature CD4 T cells (B), and CD4 lymphocytes express the compa-while the expression of inappropriate cytokines of the
rable levels of other cell surface markers (C). The histograms shownalternative lineage is extinguished (Kamogawa et al.,
in (C) are gated on CD4-positive cells and ten times more cells were1993; Nakamura et al., 1997). Differentiating to the Th1
collected from CIITA2/2 mice. B10.BR mice were used as a control.
lineage, therefore, should occur in parallel with extinc-
tion of IL-4 gene transcription. Although a number of
studies have demonstrated the positive regulation of expressing MHC class I would be expected to express
IL-4 gene transcription in Th2 cells, the mechanism I-E. T cells from CIITA2/2xI-E mice, but not control mice,
whereby Th1 cells downregulate IL-4 gene transcription expressed I-E on the cell surface (Figure 1A). We then
is poorly understood. We show here that the CIITA gene tested whether the expression of the I-E transgene was
is expressed in cells differentiating to Th1 but not Th2. sufficient to reconstitute the CD4 T cell compartment in
Furthermore, the expression of the CIITA gene mediates CIITA2/2 mice. Total lymph node cells were stained with
the downregulation of IL-4 gene transcription in Th1 antibodies recognizing CD4 and CD8, and the expres-
cells and plays a critical role in the establishment of sion profile is shown in Figure 1B. CIITA2/2xI-E mice
lineage commitment of CD4 T cells. showed matured CD4 T cells in the periphery, sug-
gesting that the expression of the transgene was suffi-
cient to mediate positive selection of CD4 T cells. Pre-
Results viously, we showed that CIITA2/2 mice have a low
residual population of CD4 T cells in the periphery. They
Generation and Characterization of CIITA-Deficient expressed a lower level of ab T cell receptor and high
Mice Expressing an MHC Class II I-E Transgene levels of cell surface markers characteristic of activated
Since CIITA is a potent transcription factor regulating T cells, CD44, CD69, and IL-2Ra (Chang et al., 1996)
immune function of antigen-presenting cells, we tested (Figure 1C). CD4 T cells of CIITA2/2xI-E mice, however,
whether CIITA also plays a role in modulating genes expressed these markers at levels comparable to the
expressed in CD4 T cells. To address this question, we control mice, demonstrating that CD4 T cells reconsti-
used CIITA2/2 mice generated by homologous recombi- tuted by the I-E transgene in CIITA2/2 mice were of
nation (Chang et al., 1996). However, these mice do not normal phenotype (Figure 1C).
have mature CD4 T cells in the periphery due to the lack
of MHC class II expression in the thymus. In order to Dysregulation of IL-4 Production in CIITA-Deficient
reconstitute the CD4 T cell population in this back- CD4 T Cells
ground, CIITA2/2 mice were crossed with transgenic We first analyzed the cytokine production using total
mice expressing the MHC class II gene I-E (CIITA2/2xI-E). CD4 T cells from spleen and lymph nodes from CIITA2/2
Since the MHC class II promoter cannot function without xI-E and the control mice. Total CD4 T cells were en-
CIITA, the transgene expression was driven by the MHC riched by eliminating APC and stimulated with immobi-
class I promoter. lized anti-CD3 antibody without exogenous cytokines
We first analyzed the MHC class II expression in these in the culture for 4 days. The cells were then washed
mice by flow cytometry. As shown in Figure 1A, B cells and equal numbers of cells were restimulated in the
derived from CIITA2/2xI-E mice expressed I-E on the presence of anti-CD3 for one more day. The supernatant
cell surface at a level that is comparable to that of the was harvested and analyzed for IL-4 and IFNg produc-
control wild-type mice (B10.BR). Since the I-E expres- tion by ELISA. Surprisingly, CD4 T cells from CIITA2/2
xI-E produced a higher level of IL-4 compared to thatsion is driven by the MHC class I promoter, other cells
Repression of IL-4 Production by CIITA
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of the control, although the IFNg levels were comparable
(Figure 2A). Since we have used enriched CD4 T cells
without purification to measure the cytokine production,
it is possible that other IL-4 producing cells such as
NK1.11 T cells or mast cells are contaminated in the
culture and contribute to the skewed production of IL-4.
Furthermore, IL-4 produced by preactivated CD4 T cells
has been shown to be capable of driving naive CD4 T
cells into T helper 2 (Th2) cells in vitro (Bradly et al.,
1991; Gollob and Doffman, 1994). To eliminate these
possibilities, we purified naive CD4 T cells to measure
the cytokine production.
Naive CD4 T cells differentiate to Th1 and Th2 effector
cells. This differentiation program can be initiated in
vitro by stimulating naive CD4 T cells with antigens or
mitogens in the presence of the cytokine IL-12 or IL-4,
which drives the differentiation of Th1 and Th2, respec-
tively. In order to determine whether the high level IL-4
production by total T cells is due to the lack of CIITA
and whether CIITA plays a role in the process of T cell
differentiation, naive CD4 T cells expressing CD44low
CD45RBhigh were purified by flow cytometry. Sorting
CD44low T cells also eliminates NK1.11 CD4 T cells, since
they express high levels of CD44 on the cell surface
(Bendelac et al., 1997). Purified naive CD4 T cells were
then cultured for 4 days with immobilized anti-CD3 anti-
body in the presence of either IL-12 or IL-4. Cells were
then washed extensively, and the same numbers of cells
were restimulated in the presence of anti-CD3 antibody
without cytokines. As shown in Figure 2B, CD4 T cells
from both control and CIITA2/2xI-E mice produced com-
parable levels of IL-4 but did not produce IFNg if IL-4
was added to the primary culture. Conversely, when
CD4 T cells from control mice were cultured in the pres-
ence of IL-12, they produced IFNg but not IL-4, as ex-
pected. Surprisingly, CD4 T cells of CIITA2/2xI-E mice
produced not only IFNg but also high levels of IL-4 in
the presence of IL-12 in the primary culture. Therefore,
IL-4 production was not regulated properly in CIITA-
deficient CD4 T cells as they differentiate to Th1 cells.
The results suggest that CIITA plays a negative role in
IL-4 production without affecting Th1 cytokine produc-
tion such as IFNg during Th1 differentiation.
A number of potential mechanisms might explain
Figure 2. Dysregulation of IL-4 Production by CIITA-Deficient CD4 these results. Since I-E is the only selecting ligand for
T Cells T cells, rather than I-A and I-E in the thymus of these
(A) Total CD4 T cells from spleen and lymph nodes from the control transgenic mice, the T cell repertoire might be altered
(B10.BR) and CIITA2/2xI-E mice were stimulated for 4 days with in some way. Alternatively, since T cells of CIITA2/2xI-E
anti-CD3 antibody without exogenous cytokines and restimulated
mice express MHC class II molecules on their cell sur-with anti-CD3 for one more day. The supernatant after secondary
face, it is possible that I-E might mediate the signalingstimulation was analyzed for IL-4 and IFNg by ELISA.
processes to produce IL-4 in the presence of IL-12. To(B) Naive CD4 T cells from CIITA2/2xI-E but not control (B10.BR) or
Ab2/2xI-E mice produce IL-4 in the presence of IL-12. The superna- test these hypotheses, we generated Ab2/2xI-E mice
tant was assayed for IL-4 or IFNg by ELISA. Three independent expressing the same MHC class I promoter±driven I-E
experiments gave comparable results and results of one representa- transgenes in mice deficient for the MHC class II struc-
tive experiment are shown here.
tural gene Ab (Ab2/2) (Cosgrove et al., 1991; Grusby et(C) IL-4 gene transcription from IL-12-treated CD4 T cells in the
al., 1991). Ab2/2 mice do not have mature CD4 T cellsabsence of CIITA. Naive CD4 T cells from control (B10.BR),
Ab2/2xI-E, and CIITA2/2xI-E mice were sorted and stimulated for 2 in the periphery, but the expression of the same I-E
days with anti-CD3 in the presence of cytokines. mRNA was pre- transgenes reconstituted the CD4 T cell compartment
pared and RT±PCR was performed using primers described in Ex- in Ab2/2xI-E mice (data not shown). CD4 T cells from
perimental Procedures.
Ab2/2xI-E mice are also selected on I-E and express(D) CIITA-deficient CD4 cells transcribe IL-5 and IL-13 upon stimulation
MHC class II on T cells; therefore, Ab2/2xI-E mice servewith either IL-4 or IL-12. Cells were treated and assayed as in (C).
as a proper control for CIITA2/2xI-E. When naive CD4 T
cells of Ab2/2xI-E were cultured with cytokines, they
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produced IL-4 and IFNg with IL-4 and IL-12 stimulation,
respectively (Figure 2B). In contrast to CD4 T cells from
CIITA2/2xI-E, IL-4 was not detectable in the supernatant
from the culture of CD4 T cells from Ab2/2xI-E stimulated
with IL-12 (Figure 2B). Therefore, IL-4 production ob-
served in CIITA-deficient CD4 T cells is due to the lack
of CIITA and not to an altered repertoire nor to signaling
mediated by MHC class II molecules on the surface of
T cells.
We further tested whether the IL-4 production ob-
served in CIITA2/2xI-E mice is likely to be due to an effect
on IL-4 gene expression. Consistent with the ELISA data,
CD4 T cells from control or Ab2/2xI-E mice transcribe
IL-4 when cells were stimulated with IL-4 but not IL-12
(Figure 2C). In contrast, CD4 T cells deficient in CIITA
express IL-4 under both culture conditions. As ex-
pected, the levels of IFNg expression were comparable
among CD4 T cells. Interestingly, CIITA-deficient CD4
T cells also transcribed IL-5 and IL-13 upon stimulation
in the presence of IL-12, suggesting that CIITA regulates Figure 3. The Expression of the CIITA and the MHC Class II Gene
not only IL-4 but also other Th2-type cytokine produc- in Th1 Cells
tion (Figure 2D). (A) Naive CD4 T cells of control mice (C57BL/6) from spleen and
lymph nodes were stimulated with anti-CD3 antibody in the pres-
ence of either IL-4 or IL-12 for 2 days. The levels of transcripts ofCIITA and MHC Class II Expression in Th1 Cells
the CIITA and the MHC class II (Aab) gene are inducible in cellsPreviously, we have reported that mouse T cells do not
stimulated with IL-12 but not IL-4.
express the CIITA gene upon stimulation with mitogens (B) IFNg is necessary to activate CIITA gene transcription. Naive
such as anti-CD3 or concanavalin A (Con A) (Chang et CD4 T cells were stimulated with the same condition as in (A). Anti-
al., 1995). However, our data presented here demon- IFNg (H22) was used to block endogenously produced IFNg in the
culture. The PCR products were fractionated on an agarose gel,strate that CIITA negatively regulates transcription of
transferred, and hybridized with radiolabeled CIITA and Aab genes.the IL-4 gene. This predicts that the CIITA gene should
Results of one representative experiment of four independent exper-be expressed in T cells during differentiation and the
iments are shown here.
expression pattern might differ depending on the envi-
ronment, especially in response to exogenous cytokine
that may trigger differentiation stimulation. We therefore of type 1 pulmonary granuloma formation elicited with
reexamined CIITA expression in T cells. Using sorted polymer beads coated with purified protein derivative
naive CD4 T cells from control mice, CIITA expression of Mycobacterium bovis (PPD). It has been shown that
was monitored 2 days after primary stimulation. As PPD induces an immune response characterized by the
shown in Figure 3A, the CIITA gene is induced after type 1 (IFNg/IL-2) cytokine profile, indicating the involve-
stimulation in the presence of IL-12 but not IL-4. We ment of Th1 cells (Chensue et al., 1994, 1995). If CIITA-
next tested whether the induction of the CIITA gene deficient mice produce IL-4 with Th1 antigen, the size
transcription by IL-12 treatment is direct or mediated of granuloma formation mediated by PPD should be
through IFNg. When naive CD4 T cells were treated with smaller than in the control mice. To test this, CIITA2/2xI-E
IL-12 in the presence of the antibody to block endoge- and the control Ab2/2xI-E mice were sensitized with PPD
nously produced IFNg, the CIITA transcripts were not subcutaneously, and they were challenged again with
detectable, demonstrating that CIITA gene transcription sepharose 4B beads covalently coupled with PPD. The
depends on IFNg (Figure 3B). Consistent with previous lungs were harvested and embolization-elicited gran-
observations (Steimle et al., 1993; Chang et al., 1994), ulomas were examined 4 days postinjection. As expected
CIITA-expressing cells express the MHC class II gene from in vitro data, the cross-sectional area of PPD-elic-
as well (Figure 3A). It is unlikely that transcripts of CIITA ited lesions was decreased by 40% in CIITA2/2xI-E mice
and MHC class II genes were derived from contaminated (Figure 4A). In order to determine whether the decrease
APC in T cell preparation. We eliminated the possibility in the granuloma lesion size in CIITA2/2I-E mice corre-
of B cell contamination by testing the expression of lated to the increased level of IL-4, we examined the
CD19, which is restricted to B cells. CD19 transcripts IL-4 production. Total CD4 T cells were enriched from
were not detectable by RT±PCR from the same RNA mice challenged with PPD and stimulated in vitro with
sample (data not shown). We also stained cells for ester- PPD in the presence of APC or Con A. In comparison
ase activity, which is specific for macrophages, and we to the control, CD4 T cells deficient in CIITA produced
did not observe any esterase-positive cells after sorting more IL-4 upon stimulation with either PPD or Con A
(data not shown). (Figure 4B). The IFNg levels are comparable between
two groups, indicating that PPD-specific T cells have
differentiated to Th1 by sensitization (Figure 4B). There-Effect of IL-4 Produced by Th1 Cells on Type 1
Pulmonary Granuloma Size fore, the decrease in the granuloma size in CIITA2/2xI-E
mice may be due to the elevated IL-4 production, not aIn order to assess the functional significance of IL-4
produced by Th1 CD4 cells in vivo, we have used a model decrease in the IFNg level.
Repression of IL-4 Production by CIITA
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Figure 4. The Effect of CIITA Deficiency on Type 1 Pulmonary Gran-
uloma Size and Cytokine Production
(A) Cross-sectional area of day 4 type 1 bead pulmonary granulomas
in mice. There were six mice per group, with a minimun of 20 granulo-
mas measured per animal.
(B) IL-4 and IFNg production by CD4 T cells from CIITA2/2xI-E and
Ab2/2xI-E mice after challenge with PPD. Two weeks after sensitiza-
Figure 5. CIITA Activates the Expression of MHC Class II but Re-tion with PPD in vivo, 3 3 105 enriched CD4 T cells were stimulated
presses IL-4 in D10 Cellsin vitro with PPD (5 mg/ml) or Con A (2.5 mg/ml) in the presence
of irradiated B10.BR splenocytes as APC. The supernatant was (A) D10 cells were stably transfected with CIITA or DNA encoding
collected 2 days later and IL-4 and IFNg production was measured the neomycin gene as a control. The transfectants were tested for
by ELISA. the expression of T cell receptor (H57) and MHC class II (14.4.4S)
by flow cytometry. Three clones showed a similar phenotype, and
one of them was used for the experiment.
(B) CIITA downregulates IL-4 production in D10 cells. D10 cells andRepression of IL-4 Production by CIITA
D10 cells transfected with CIITA were stimulated in the presence
in Th2 Cells of 5 mg/ml of plate-bound anti-CD3 antibody. The supernatant and
Our data suggests that the lack of CIITA causes dysregu- cells were collected for ELISA and RNA preparation, respectively,
lation of IL-4 production, and the role of CIITA in T cells at indicated times after stimulation. RT±PCR was performed using
different amounts of first strand cDNA product to measure IL-4is to downregulate IL-4 gene expression during Th1 dif-
transcripts.ferentiation. If our hypothesis is correct, the introduction
(C) CIITA represses transcription of the IL-5 and the IL-13 gene.of CIITA to Th2 cells should repress the IL-4 production.
Cells transfected with the control DNA or CIITA were stimulated
To test this hypothesis, we performed transfection with anti-CD3 as in (B). RNA was prepared 2 hr and 24 hr after
assays using a well-characterized Th2 clone, D10 (Kaye stimulation, and RT±PCR was performed using primers specific for
et al., 1983). D10 cells were stably transfected with CIITA IL-5 and IL-13.
or an empty vector DNA, and the transfectants were
first examined for the expression of T cell receptor and
MHC class II molecules on the cell surface. As shown DNA, supporting the notion that CIITA downregulates
IL-4 production (Figure 5B). The reduction of IL-4 proteinpreviously (Chang et al., 1995), CIITA activated the MHC
class II expression on the T cell surface, although the is due to the decreased amounts of IL-4 transcripts in
CIITA-transfected D10 cells (Figure 5B). The levels oflevel of TCR remains the same between the cells trans-
fected with the control DNA and CIITA (Figure 5A). To IL-5 and IL-13 transcripts were also reduced in CIITA-
transfected D10 cells, demonstrating that CIITA regu-analyze IL-4 production, cells were stimulated with anti-
CD3 antibody and the supernatant was harvested at lates the expression of Th2 type cytokines (Figure 5C).
To further investigate whether CIITA represses thedifferent time points as indicated to measure IL-4 by
ELISA. As shown in Figure 5B, D10 cells transfected IL-4 transcription directly, we performed transient trans-
fection assays using D10 cells. D10 cells were trans-with the control DNA produced IL-4 upon stimulation.
Similarly, CIITA-transfected D10 cells also produced fected with the 3.0 kb IL-4 promoter±driven luciferase
as a reporter with or without CIITA. As shown in FigureIL-4 with stimulation, but the amount of IL-4 in the super-
natant was reduced compared to that of the control 6A, the level of IL-4 expression was reduced when sense
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box binding protein (TBP) and the TBP-associated factor
TAFII32 is critical to CIITA-mediated transactivation
(Fontes et al., 1997; Mahanta et al., 1997). Furthermore,
CIITA interacts with the B cell±specific transcription fac-
tor BOB (Fontes et al., 1996) and RFX, which is required
for MHC class II gene expression (Scholl et al., 1997).
A recent study demonstrated that CIITA is required for
the assembly of transcription factors specifically on the
MHC class II and associated genes, although this effect
is limited in IFNg-inducible cell types (Wright et al., 1998).
It is not surprising, therefore, that CIITA might interact
with many different proteins; the nature of the interaction
between CIITA and specific DNA binding proteins or
coactivators dictates the outcome.
It is not yet clear how CIITA modulates the expression
of different sets of genes, activating the MHC class II
genes but repressing the IL-4 gene. One possibility is
that CIITA may interact with a transcription factor(s) and
form a protein±protein complex. This might occlude the
DNA binding site for a given transcription factor to the
IL-4 promoter or disturb the overall configuration of tran-
scriptional complex, resulting in downregulation of tran-
scription.
Alternatively, CIITA may activate or interact with a
Figure 6. CIITA Represses IL-4 Gene Transcription in D10 Cells
negative regulatory factor(s), which in turn represses
D10 cells were transfected with the IL-4 promoter±driven luciferase
IL-4 gene transcription. Studies have shown that the(A) or the MHC class II promoter±driven luciferase (B) with the empty
expression of the IL-4 gene is negatively regulated byvector DNA, sense CIITA, or antisense CIITA. (C) The 157 bp frag-
several mechanisms (Li Weber et al., 1992, 1993, 1994;ment of the IL-4 promoter is sufficient to be repressed by CIITA.
The fragment encompassing 157 bp or 3 kb of the IL-4 promoter Trinchieri, 1995; Abbas et al., 1996; Klein-Hessling et
was transfected with CIITA or the control DNA. The cells were har- al., 1996; Kubo et al., 1997; Szabo et al., 1997). The
vested and analyzed for luciferase activity 2 days after transfection. human IL-4 gene promoter contains negative elements
Expression units were calculated using the luciferase activity of
designated NRE1 and NRE2 (Li Weber et al., 1992).cells transfected with control DNA as 1. The values shown were
These elements were defined in Jurkat cells and havenormalized to b-gal activity (internal control).
significant homology to previously characterized nega-
tive regulatory elements (Smith and Greene, 1989; Bani-
ahmad et al., 1990). Two distinct DNA±protein com-CIITA was cotransfected together with the reporter but
plexes were detected; one is Th1-cell specific and thenot with the control DNA or antisense CIITA. This repres-
other is more ubiquitous (Li Weber et al., 1993). Thesesion was not observed when a MHC class II promoter
NREs inhibit the activity of the adjacent positive regula-reporter was used. Rather, MHC class II promoter±
tory element without repressing the basal promoter.driven luciferase activity was induced by transfection
Another cis element, a silencer containing the Stat6-with CIITA in the sense orientation as shown previously
binding site in the 39 untranslated region of the IL-4(Chang et al., 1995; Figure 6B), demonstrating target
gene, mediates a negative effect on IL-4 gene transcrip-site specificity for both activation and repression by
tion (Kubo et al., 1997). T cell subset-specific expressionCIITA. In order to delineate the IL-4 promoter responsi-
of the IL-4 gene is regulated by this silencer and it isble for repression by CIITA, we tested the IL-4 promoter
active in Th1 cells by an unknown mechanism. Further-encompassing 157 bp, which is sufficient for Th2-spe-
more, Stat6 binding to the silencer plays a permissivecific expression (Todd et al., 1993). As shown in Figure
role in determining the commitment into Th2 cells. An6C, CIITA downregulated the 157 bp promoter-driven
attractive possibility is that CIITA regulates a factor(s)luciferase at the same degree as the 3 kb promoter,
binding to either NREs or the silencer or interacts withsuggesting that a element(s) residing within the 157 bp
a negative regulatory factor(s) and thus inhibits IL-4 genefragment is sufficient to mediate the repression by CIITA.
transcription in Th1 cells. A thorough analysis of the
negative cis elements and their interacting proteins willDiscussion
be necessary to understand the relationship between
CIITA and other negative regulatory factors.It is believed that CIITA is a transcriptional activator for
Studies have shown that the IL-4 gene expression ismultiple genes involved in antigen presentation: MHC
also repressed directly and indirectly by IFNg (Li Weberclass II, invariant chain, and H-2M genes (Steimle et al.,
et al., 1994; Trinchieri, 1995; Abbas et al., 1996; Szabo1993, 1994; Chin et al., 1994; Chang et al., 1994, 1995;
et al., 1997). The human IL-4 promoter contains an IFN-Chang and Flavell, 1995). We have shown here that in
stimulation response element (ISRE) and the mutation ofaddition to its role in the activation of genes involved in
ISRE increases the IL-4 reporter gene activity, sug-antigen presentation, CIITA also represses the IL-4 gene
gesting a role for ISRE as a negative regulator of tran-transcription. Recent studies have shown that the inter-
action between CIITA and multiple regions of the TATA scription (Li Weber et al., 1994). IFNg also exerts its
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downregulatory effects on Th2 cell differentiation by
inducing APC to produce IL-12 and by maintaining IL-
12 responsiveness in T cells (Trinchieri, 1995; Abbas et
al., 1996; Szabo et al., 1997). We believe that IFNg-
mediated inhibition of the IL-4 gene expression is also
partly due to the elevated level of CIITA by IFNg during
Th1 cell differentiation as shown in this study.
Finally, it has been reported that HMG I(Y) exerts a
suppressive effect on IL-4 promoter induction (Klein-
Hessling et al., 1996). This suppression is mediated by
interference of the DNA binding of NF-AT factors by
HMG I(Y). NF-AT proteins, composed of several mem-
bers, are well established as regulators of multiple cyto-
kine genes expressed in T cells, including IL-4 (Durand
et al., 1988; Cockerill et al., 1993; Goldfeld et al., 1993;
Rooney et al., 1995; Hodge et al., 1996b; Rao et al.,
1997). Disrupting one of these members, NF-ATc in par-
ticular, by gene targeting impairs production of IL-4
(Ranger et al., 1998; Yoshida et al., 1998). Therefore, it
is not surprising that interfering in NF-AT binding to IL-4
promoter by HMG I(Y) suppresses transcription. It is
interesting to note that the level of IL-4 promoter induc-
Figure 7. The Cascade of CD4 T Cell Differentiationtion correlates with HMG I(Y) concentration, and Th2 cell
lines, including D10, have lower HMG I(Y) concentration
(Klein-Hessling et al., 1996). It is reasonable, therefore,
to speculate that CIITA in Th1 cells upregulates HMG affecting Th1-type cytokines. We also have tested the
I(Y) and, subsequently, that the elevated HMG I(Y) inhib- level of GATA-3, a major transcription factor activating
its the binding of NF-ATc to the IL-4 promoter and re- all Th2-specific cytokines. It has been reported that the
presses IL-4 gene transcription. However, the transcript GATA-3 level changes during T cell differentiation: the
level of HMG I(Y) remains the same with and without level of GATA-3 transcripts increases in Th2 but de-
CIITA (S. R. and C.-H. C., unpublished data), and there- creases in Th1 cells (Zhang et al., 1997; Zheng and
fore it seems unlikely that CIITA regulates the expression Flavell, 1997). One possibility is that CIITA downregu-
of HMG I(Y). We cannot rule out the possibility that CIITA lates GATA-3 expression and in turn inhibits IL-4 tran-
affects HMG I(Y) function posttranscriptionally. scription in Th1 cells. However, GATA-3 mRNA levels
We have observed that CIITA downregulates the en- remain the same regardless of the CIITA status (T. G.
dogenous IL-4 production and the IL-4 promoter±driven and C.-H. C., unpublished data). Therefore, it seems that
reporter gene expression in D10 cells (Figures 5B and CIITA does not regulate the expression of GATA-3.
6). Our data indicates that cis-acting elements residing Nevertheless, IL-12 and IFNg probably mediate one
within the 157 bp fragment are sufficient to mediate of their effects favoring the Th1 development by the
repression by CIITA (Figure 6). Although it is not yet clear activation of CIITA and the repression of Th2-type cyto-
how CIITA represses the IL-4 promoter, it is tempting to kine gene expression. Upon initiation of the innate im-
speculate that NF-AT may play a role, since there are mune response, macrophages are activated and pro-
multiple NF-AT sites within the 157 bp fragment of the duce IL-12, resulting in Th1 cell lineage commitment
IL-4 promoter. In addition, NF-AT sites are present in (Figure 7). As a consequence, Th1 cells produce IFNg,
IL-5 and IL-13 promoters (Prieschl et al., 1995; Dolganov which in turn induces the transcription of the CIITA gene
et al., 1996). However, CIITA by itself is not sufficient to while it suppresses IL-4 gene transcription. IFNg also
repress IL-4 gene transcription completely. It could be has been shown to prevent early Th cells from premature
due to the cell line used for our study, which is a differen- commitment to the Th2 pathway by maintaining IL-
tiated Th2 clone D10. Th2 cells may lack additional regu- 12Rb2 chain expression (Szabo et al., 1997). Further-
latory factors recognizing NREs and the silencer, and more, several transcription factors necessary for IL-4
these factors may be required to shut off IL-4 gene gene transcription are expressed preferentially in Th2
transcription (Li Weber et al., 1993; Kubo et al., 1997). cells, allowing IL-4 gene induction. The balance between
Furthermore, Stat6 is expressed in Th2 cells and deacti- positive and negative regulatory factors for cytokine
vates the effect of the silencer (Kubo et al., 1997). It is gene expression is likely to be critical to maintaining the
not surprising, therefore, to see the relatively lower level proper differentiation pathways of CD4 effector cells.
of inhibition of IL-4 gene transcription by introducing Disruption of one of these factors causes dysregulation
of cytokine production as shown in this study. It shouldCIITA alone to Th2 cells. We have shown more a pro-
found effect of IL-4 gene dysregulation by eliminating be noted that mouse Th1 cells can transcribe MHC class
II genes (Figure 3), but the RNA level is too low to resultCIITA during Th1 cell differentiation. Taken together, our
data suggests that CIITA is necessary but not sufficient in protein expression on the surface of Th1 cells (T. G.
and C.-H. C., unpublished data). Interestingly, however,to completely repress IL-4 gene transcription in Th1 cells.
CIITA is a transcription factor modulating the expres- mouse Th1 cells specific for viral peptides have been
shown to express MHC class II on the cell surfacesion of Th2-type cytokines, IL-4, IL-5 and IL-13, without
Immunity
384
and CD8 (TIB 105 and TIB 210), followed by incubation with anti-(Thomas et al., 1996). A Th2 clone with the same specific-
mouse Ig- and anti-rat Ig-coated magnetic beads. Cells were cul-ity did not express MHC class II. Therefore, it is very
tured in the presence of 5 mg/ml immobilized anti-CD3 (2C11) for 4possible that mouse T cells express MHC class II mole-
days. Cells were then washed and restimulated with immobilized
cules under a certain environment and mediate the im- anti-CD3 for 1 day. The supernatant was analyzed for ELISA. Naive
mune response in vivo. CD4 T cells were prepared from the lymph nodes and spleen using
the same method as for the preparation of total CD4 T cells. TheseWe presented evidence in this study that the lack of
cells were further purified by sorting of CD41, CD45RBhigh, andCIITA causes elevated levels of IL-4 production during
CD44low populations. Naive CD4 T cells were cultured at 1 3 105 todifferentiation to the Th1 lineage both in vitro and in vivo
1 3 106 cells/ml in the presence of 5 mg/ml immobilized anti-CD3(Figures 2B and 4). The elevated level of IL-4 clearly
(2C11), 10 U/ml of IL-2 (NIH), and 3.5 ng/ml of IL-12 (Pharmingen)
has pathophysiologically relevant consequences in vivo or 1000 U/ml of IL-4 (Pharmingen). After 4 days, cells were washed
shown by the type 1 granuloma development, which extensively, counted, and restimulated with immobilized anti-CD3
overnight. For RNA preparation, naive CD4 cells were stimulateddepends on the ability to generate a Th1-dominated
for 2±3 days and harvested.immune response (Chensue et al., 1994, 1995). Indeed,
mice deficient in CIITA developed smaller granulomas
Cytokine Assayswith PPD than the control mice, consistent with the
ELISAs were used to assay for IL-4 and IFNg in culture supernatants.
increased level of IL-4 in CIITA-deficient CD4 T cells An IL-4 ELISA using mAbs specific for murine IL-4 (Pharmingen)
(Figure 4). This is consistent with the observation in and an IFNg ELISA using mAbs specific for murine IFNg (Phar-
IL-4-deficient mice that showed increased granuloma mingen) have been described previously (Nakamura et al., 1997). A
standard curve for each assay was generated with a known concen-development upon PPD challenge (Chensue et al., 1997).
tration of murine recombinant cytokines (Pharmingen).Notably, the levels of IFNg were comparable in CD4 T
cells of both mice. Perhaps the production of both IL-4
Plasmids and Transfectionand IFNg by Th1 cells dampens the effect of IFNg in the
The CIITA cDNA was described (Chang et al., 1994). D10 cells were
granuloma development. A prediction of our results from maintained in Click's medium supplemented with 10% fetal bovine
CIITA-deficient cells is that the forced expression of serum, 2 mM glutamine, 100 mg/ml penicillin and streptomycin, and
1025 M b-ME. D10 cells were stimulated with 100 mg/ml of conalbu-CIITA in all CD4 T cells would downregulate IL-4 produc-
min (Sigma) and splenocytes from B10.BR mice every 2 weeks. Fortion and thus allow an enhanced Th1 population in vivo.
stable transfection, 1 3 107 D10 cells were electroporated using theThis possibility is currently under investigation. In con-
Gene Pulser apparatus (Biorad) at 300 V and 960 mF. One day afterclusion, our data demonstrate that CIITA behaves not
transfection, cells were stimulated with 100 mg/ml of conalbumin
only as a positive transcriptional factor but also as a (Sigma) and 1 3 107 irradiated B10.BR splenocytes. Cells were se-
negative regulator, depending upon the target promoter. lected in media containing 1 mg/ml of G418 (Geneticin; GIBCO±
BRL). Transient transfection was performed using DEAE-dextran.
Typically, 3±4 3 106 cells were transfected with 5 mg of each plasmidExperimental Procedures
DNA by incubating 30 min in the presence of 2 mg/ml DEAE-dextran.
One day after transfection, cells were stimulated with 100 mg/ml ofMice
conalbumin (Sigma) and 1 3 107 irradiated B10.BR splenocytes forCIITA2/2 and Ab2/2 mice were described previously (Cosgrove et
one more day. Protein extracts were prepared and the luciferaseal., 1991; Grusby et al., 1991; Chang et al., 1996). CIITA2/2xI-E and
activity was measured using LB 953 Autolumat (EG and G Berthold,Ab2/2xI-E transgenic mice were generated by crossing CIITA2/2 or
Germany). b-galactosidase (b-gal) assays were done as describedAb2/2 mice with I-E transgenic mice. The transgene was constructed
(Ausubel et al., 1989).using the MHC class I H-2Kb promoter (22015 to 112) to express
5 kb of Ead genomic DNA and Ebb cDNA. C57BL/6 and B10.BR mice
Induction of Pulmonary Granulomaswere obtained from the Jackson Laboratory. Mice were kept under
Mice were sensitized by subcutaneous injection near the nape ofspecific pathogen-free environments at Yale University and the Uni-
the neck with 20 mg of Mycobacterium bovis PPD incorporated intoversity of Michigan Medical School.
0.25 ml of CFA. Fourteen to sixteen days later, mice were challenged
intravenously with 0.5 ml PBS containing 4000 sepharose 4B beadsCytofluorometric Analyses
covalently coupled with PPD obtained from the National VeterinaryLymph node cell suspensions were prepared in Click's medium and
Services Laboratories. Beads embolized to the lungs elicited granu-erythrocytes were lysed by hypotonic shock. Cells were resus-
lomas that were examined 4 days postinjection as describedpended in cold PBS supplemented with 1% fetal bovine serum.
(Chensue et al., 1997).Staining was performed in the same buffer. The following antibodies
used in experiments were purchased from Pharmingen: 14.4.4S for
AcknowledgmentsI-E, H129.1.9 for CD4, 53±6.7 for CD8, H57±597 for ab TCR, IM7 for
CD44, H1.2F3 for CD69, and 7D4 for IL-2Ra chain. RA3±6B2 and
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